In research, COI can lead to biased study designs, selective reporting, or misinterpretation of data. For instance, if a toxicologist receives funding from a company whose product is under study, there might be a conscious or unconscious bias towards favorable results. This can skew the scientific literature and influence regulatory bodies and policymakers who rely on this research to make decisions about the safety and regulation of substances.
